HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphorylation of S6 Protein as a Potential Biomarker in Surgically Treated Refractory Epilepsy.

Abstract
The tuberous sclerosis complex (TSC), focal cortical dysplasia IIB (FCD IIB), and hemimegalencephaly (HME) exhibit similar molecular features that are dependent on the hyperactivation of the mTOR pathway. They are all associated with refractory epilepsy and the need for surgical resection with varying outcomes. The phosphorylated protein S6 (pS6) is a downstream target of mTOR, whose increased expression might indicate mTOR hyperactivation, but which is also present when there is no alteration in the pathway (such as in FCD type I). We have performed immunohistochemical marking and quantification of pS6 in resected brain specimens of 26 patients clinically and histologically diagnosed with TSC, FCD IIB, or HME and compared this data to a control group of 25 patients, to measure the extent of pS6 positivity and its correlation with clinical aspects. Our results suggest that pS6 may serve as a reliable biomarker in epilepsy and that a greater percentage of pS6 marking can relate to more severe forms of mTOR-dependent brain anomalies.
AuthorsFelipe I Chodraui, Camila Araújo B Garcia, Niele D Mendes, Marcelo V Santos, Pâmela S Beggiora, Stephanya C Silva, Thiago L Teixeira, Luiza da Silva Lopes, Fabiano P Saggioro, Luciano Neder, Hélio R Machado
JournalDevelopmental neuroscience (Dev Neurosci) Vol. 42 Issue 5-6 Pg. 230-236 ( 2020) ISSN: 1421-9859 [Electronic] Switzerland
PMID33706310 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 S. Karger AG, Basel.
Chemical References
  • Biomarkers
  • Ribosomal Protein S6
Topics
  • Adolescent
  • Biomarkers (metabolism)
  • Child
  • Child, Preschool
  • Drug Resistant Epilepsy (etiology, metabolism, surgery)
  • Epilepsy (complications, metabolism, surgery)
  • Female
  • Hemimegalencephaly (complications, metabolism, surgery)
  • Humans
  • Infant
  • Male
  • Malformations of Cortical Development, Group I (complications, metabolism, surgery)
  • Phosphorylation
  • Ribosomal Protein S6 (metabolism)
  • Tuberous Sclerosis (complications, metabolism, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: